NCT06485453View on ClinicalTrials.gov

Predictive Urodynamic Parameters for The Treatment Efficacy of Onabotulinum A Toxin in Neurogenic Lower Urinary Tract Dysfunction

CompletedOBSERVATIONAL
Enrollment

74

Participants

Timeline

Start Date

September 1, 2013

Primary Completion Date

September 1, 2023

Study Completion Date

June 1, 2024

Conditions
Neurogenic Bladder Disorder
Interventions
DRUG

Botox 200 UNT Injection

Treatment effect and duration of Onabotulinum Toxin A according to patient's pad usaged

All Listed Sponsors
lead

University of Gaziantep

OTHER

NCT06485453 - Predictive Urodynamic Parameters for The Treatment Efficacy of Onabotulinum A Toxin in Neurogenic Lower Urinary Tract Dysfunction | Biotech Hunter | Biotech Hunter